LOS ANGELES–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24BSX&src=ctag” target=”_blank”gt;$BSXlt;/agt; lt;a href=”https://twitter.com/hashtag/BostonScientific?src=hash” target=”_blank”gt;#BostonScientificlt;/agt;–The
Schall Law Firm, a national shareholder rights litigation firm,
announces the filing of a class action lawsuit against Boston Scientific
Corporation (“Boston Scientific” or “the Company”) (NYSE: BSX)
for violations of §§10(b) and 20(a) of the Securities Exchange Act of
1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and
Exchange Commission.
Investors who purchased the Company’s shares between February 26, 2015
and April 16, 2019, inclusive (the “Class Period”), are encouraged to
contact the firm before June 24, 2019.
If you are a shareholder who suffered a loss, click
here to participate.
We also encourage you to contact Brian Schall, or Sherin Mahdavian, of
the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA
90067, at 424-303-1964, to discuss your rights free of charge. You can
also reach us through the firm’s website at www.schallfirm.com,
or by email at [email protected].
The class, in this case, has not yet been certified, and until
certification occurs, you are not represented by an attorney. If you
choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading
statements to the market. Boston Scientific’s surgical mesh products for
transvaginal repair of POP were not safe for usage. The Company’s
continued marketing and sales of surgical mesh in the U.S. were not
sustainable based on this issue. The Company also sold surgical mesh
products containing counterfeit materials from China. Based on these
facts, the Company’s public statements were false and materially
misleading throughout the class period. When the market learned the
truth about Boston Scientific, investors suffered damages.
Join
the case to recover your losses.
The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder rights
litigation.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.
Sherin Mahdavian, Esq.
www.schallfirm.com
Office:
310-301-3335
Cell: 424-303-1964
[email protected]
